Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current epidemiology of cholangiocarcinoma in Western countries
Mathew Vithayathil, Shahid A. Khan
Journal of Hepatology (2022) Vol. 77, Iss. 6, pp. 1690-1698
Closed Access | Times Cited: 104

Showing 26-50 of 104 citing articles:

Phosphorylation enhanced OTUD3 deubiquitination ARID3A promotes the progress of cholangiocarcinoma
Deng‐Yong Zhang, Yan Zhu, Shuoshuo Ma, et al.
Oncogene (2025)
Closed Access
Metabolic Reprogramming in Cholangiocarcinoma Cancer Stem Cells: Emerging Therapeutic Paradigms
Qi Wang, Timothy E. Long, Peili Tang, et al.
Cancer Letters (2025), pp. 217714-217714
Closed Access
Molecular portraits of patients with intrahepatic cholangiocarcinoma who diverge as rapid progressors or long survivors on chemotherapy
Colm J. O’Rourke, Massimiliano Salati, Colin Rae, et al.
Gut (2023), pp. gutjnl-330748
Open Access | Times Cited: 12
Molecular Profile of Intrahepatic Cholangiocarcinoma
Wellington Andraus, Francisco Tustumi, José Donizeti de Meira Júnior, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 461-461
Open Access | Times Cited: 12
An overview of extrahepatic cholangiocarcinoma: from here to where?
Yongheng Yang, Xiaolu Zhang
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 11
Contrast-Enhanced Imaging in the Management of Intrahepatic Cholangiocarcinoma: State of Art and Future Perspectives
Lucia Cerrito, Maria Elena Ainora, Raffaele Borriello, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3393-3393
Open Access | Times Cited: 11
The Search for Risk, Diagnostic and Prognostic Biomarkers of Cholangiocarcinoma and their Biological and Clinicopathological Significance
Rocı́o I.R. Macı́as, Hiroaki Kanzaki, Carmen Berasain, et al.
American Journal Of Pathology (2024)
Closed Access | Times Cited: 4
Cholangiocarcinoma: what are the options in all comers and how has the advent of molecular profiling opened the way to personalised medicine ?
Gaël S. Roth, Cindy Neuzillet, Matthieu Sarabi, et al.
European Journal of Cancer (2022) Vol. 179, pp. 1-14
Open Access | Times Cited: 18
Essential updates 2021/2022: Update in surgical strategy for perihilar cholangiocarcinoma
Fumihiro Kawano, Ryuji Yoshioka, Hirofumi Ichida, et al.
Annals of Gastroenterological Surgery (2023) Vol. 7, Iss. 6, pp. 848-855
Open Access | Times Cited: 9
The Arising Role of Extracellular Vesicles in Cholangiocarcinoma: A Rundown of the Current Knowledge Regarding Diagnostic and Therapeutic Approaches
Eleni-Myrto Trifylli, Anastasios G. Kriebardis, Evangelos Koustas, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15563-15563
Open Access | Times Cited: 9
LncRNA FALEC increases the proliferation, migration and drug resistance of cholangiocarcinoma through competitive regulation of miR-20a-5p/SHOC2 axis
Haiming Du, Senlin Hou, Lichao Zhang, et al.
Aging (2023) Vol. 15, Iss. 9, pp. 3759-3770
Open Access | Times Cited: 7
TRIB3 As an Emerging Biomarker and Potential Target for Cholangiocarcinoma: Evidence from Experiments and Bioinformatics
Chen Shen, Yijie Jiao, Yuping Lai, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 2
The rise of biliary tract cancers and next‐generation population registries
Dillon Cheung, Chee-Chee H. Stucky, Zhi Ven Fong
Cancer (2024) Vol. 130, Iss. 13, pp. 2257-2259
Closed Access | Times Cited: 2
Targeting the PI3K/AKT/mTOR pathway offer a promising therapeutic strategy for cholangiocarcinoma patients with high doublecortin-like kinase 1 expression
Ziwei Liang, Yang Ge, Li Jianjian, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 7
Open Access | Times Cited: 2
Huaier inhibits cholangiocarcinoma cells through the twist1/FBP1/Wnt/β-catenin axis
Liyuan Cong, Jian Shi, Jing Zhao, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 2
Sensitization of cholangiocarcinoma cells to chemotherapy through BCRP inhibition with β-caryophyllene oxide
Sara Ortiz-Rivero, Ana Peleteiro‐Vigil, Lorena Abete, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 170, pp. 116038-116038
Open Access | Times Cited: 6
Laparoscopic Living donor liver transplantation in irresectable intrahepatic cholangiocarcinoma in primary sclerosing cholangitis associated liver cirrhosis
Jan Bednarsch, Sven Arke Lang, Daniel Heise, et al.
Zeitschrift für Gastroenterologie (2024) Vol. 62, Iss. 01, pp. 50-55
Closed Access | Times Cited: 1
18F-fluorodeoxyglucose positron emission tomography/computed tomography in intrahepatic cholangiocarcinoma: could it be a new paradigm?
Masakatsu Tsurusaki, Ryohei Kozuki, Atsushi Urase
HepatoBiliary Surgery and Nutrition (2024) Vol. 13, Iss. 2, pp. 379-381
Open Access | Times Cited: 1
YBX1 promotes stemness and cisplatin insensitivity in intrahepatic cholangiocarcinoma via the AKT/β‐catenin axis
Xiaodong Shi, Zhiliang Hu, Shilei Bai, et al.
The Journal of Gene Medicine (2024) Vol. 26, Iss. 5
Open Access | Times Cited: 1
Identifying Telomere-Related Genes as Prognostic Biomarkers of Cholangiocarcinoma and Exploring Their Biological Functions Based on Integrated Analysis of Single-Cell and Bulk RNA Sequencing Data
Shicai Liang, Xuebo Wang, Xusheng Zhang, et al.
(2024)
Open Access | Times Cited: 1
Laparoscopic Living donor liver transplantation in irresectable intrahepatic cholangiocarcinoma in primary sclerosing cholangitis associated liver cirrhosis
Jan Bednarsch, Sven Arke Lang, Daniel Heise, et al.
TumorDiagnostik & Therapie (2024) Vol. 45, Iss. 06, pp. 382-386
Closed Access | Times Cited: 1
UCK2 promotes intrahepatic cholangiocarcinoma progression and desensitizes cisplatin treatment by PI3K/AKT/mTOR/autophagic axis
Xiwen Wu, Da Chen, Muqi Li, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Lymph node metastasis of intrahepatic cholangiocarcinoma: the present and prospect of detection and dissection
Ruoyu Zhang, Yunfei Tan, Mei Liu, et al.
European Journal of Gastroenterology & Hepatology (2024) Vol. 36, Iss. 12, pp. 1359-1369
Open Access | Times Cited: 1
The causal relationship between metabolic factors, drinking, smoking and intrahepatic cholangiocarcinoma: a Mendelian randomization study
Shanshan Qin, Guoqiang Pan, Qun-bo Meng, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 4
Viral hepatitis increases the risk of cholangiocarcinoma: a systematic review and meta-analysis
Bin Lin, Qiongxiao He, Yidan Lu, et al.
Translational Cancer Research (2023) Vol. 12, Iss. 6, pp. 1602-1616
Open Access | Times Cited: 4

Scroll to top